Dupixent gets EU nod for children with severe atopic dermatitis
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive…
January 27, 2023 - 4 minutes
Sanofi
CytoReason expands deal with Sanofi to look at IBD
CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi.…
January 24, 2023 - 2 minutes
Positive Dupixent eosinophilic esophagitis phase 3 results
The New England Journal of Medicine has published results from a positive phase 3 trial…
December 22, 2022 - 4 minutes
Sanofi and Innate Pharma expand natural killer cell deal
Sanofi and Innate Pharma SA have expanded their collaboration, with Sanofi licensing a natural killer (NK)…
December 19, 2022 - 3 minutes
European Commission approves Dupixent as first and only targeted prurigo nodularis medicine
The European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European…
December 15, 2022 - 5 minutes
Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…
December 7, 2022 - 3 minutes
FDA clears insulin pen medical device
BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices,…
December 7, 2022 - 2 minutes
TrialSpark acquires immunodermatology portfolio and creates Libertas Bio
TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position…
November 30, 2022 - 3 minutes
Sanofi’s Enjaymo for hemolytic anemia given marketing authorization by EC
Sanofi’s treatment, Enjaymo, for hemolytic anemia in adult patients with cold agglutinin disease (CAD), has…
November 18, 2022 - 4 minutes
In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus
AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the European Union (EU) for the…
November 14, 2022 - 9 minutes
Prurigo nodularis treatment recommended for EU approval
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a…
November 11, 2022 - 3 minutes
Sanofi and GSK Covid-19 booster vaccine approved by European Commission
Sanofi and GSK’s Covid booster vaccine has been approved in Europe. After the European Medicines…
November 10, 2022 - 2 minutes
